http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1545709-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2fc8c4f23758df7ed658973e2a913e38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4aca36fb2f977194f9a36f54b9c1a89
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2003-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df975e0cbe85da2b1c9aed25691585d6
publicationDate 2005-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1545709-A1
titleOfInvention Neoadjuvant treatment of breast cancer
abstract Neoadjuvant treatment of inflammatory or T3 to T4 breast cancer is carried out by administering to such patients a number of cycles of chemotherapy treatment in which DPPE first is administered followed by a combination of anthracyclines and taxanes.
priorityDate 2002-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226513554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135777125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129015506
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57003117
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395881
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57101935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID243681044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136090536
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128694270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87071517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108092
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6711468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135943377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90832756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41867

Total number of triples: 54.